Moody's downgraded twelve health systems and educational institutions in the past ninety days, citing sustained operating losses and deteriorating liquidity across $2.1 billion in outstanding debt. Brown University dropped one notch to Aa2. Regional health networks in Ohio, Pennsylvania, and the Carolinas absorbed similar cuts. The common thread: operating margins below 1.8% and days cash on hand falling beneath 120 on a trailing twelve-month basis.
The rating actions follow eighteen months of margin compression in non-profit health and education. Labor costs rose 14% year-over-year while net patient service revenue grew just 3.2%. Universities face enrollment declines averaging 6% among second-tier privates, forcing dependence on endowment draws that now exceed policy ceilings at 22 institutions tracked by Moody's higher education desk. Health systems report payer mix deterioration—Medicaid and uncompensated care now represent 31% of gross revenue at affected networks, up from 24% in 2021. Several systems burned through $40 million to $180 million in unrestricted cash during the trailing year. Moody's noted that management teams offered restructuring plans but provided limited evidence of sustainable cost discipline.
The downgrades reprice $2.1 billion in tax-exempt bonds across the twelve entities. Spreads widened 18 to 35 basis points in secondary trading within seventy-two hours of the announcements. For context, the median spread for Aa2-rated hospital debt sits at 92 basis points over the MMD AAA benchmark; newly downgraded credits now trade 110 to 127 basis points wide. That translates to an additional $3.8 million in annual interest expense per $100 million tranche at current rates. Three of the affected systems have bond calls scheduled between now and March 2026. Refinancing those maturities will reset coupons 60 to 80 basis points higher, absent material operating improvement. Endowment-backed university credits face less immediate rollover risk, but $340 million in education debt within this cohort matures by December 2027.
Allocators should track two forward indicators. First, CMS will publish updated Medicare Advantage penetration data for 2024 enrollment in mid-February. MA plans now cover 54% of Medicare beneficiaries in several downgraded systems' service areas, and those contracts reimburse at 88% of traditional Medicare rates on a risk-adjusted basis. Any acceleration past 56% penetration compresses margins another 40 basis points, all else equal. Second, Moody's has nineteen additional health and education credits on negative outlook. The agency typically resolves outlooks within twelve to eighteen months. If half convert to downgrades by Q3 2025, the sector faces another $1.4 billion in spread widening. Worth noting: five of the twelve entities downgraded this cycle were on stable outlook as recently as September.
The repricing is containable for now—$2.1 billion represents 0.4% of the $512 billion tax-exempt health and education market. But operating trends have not inflected. The median health system in this cohort reported October operating margins of 0.9%, down from 1.6% in October 2023. Labor expense per adjusted discharge rose another 220 basis points quarter-over-quarter. Management teams cite staffing stabilization, but the evidence remains anecdotal. By April, Q1 2025 financials will clarify whether restructuring plans gained traction or whether Moody's has more work ahead.